Real-World Treatment Patterns, Outcomes, Resource Utilization and Costs in Treatment-Resistant Major Depressive Disorder: PATTERN, a Retrospective Cohort Study in Belgium View Full Text


Ontology type: schema:ScholarlyArticle      Open Access: True


Article Info

DATE

2021-11-15

AUTHORS

B. Gillain, G. Degraeve, T. Dreesen, G. De Bruecker, E. Buntinx, D. Beke, C. Kestens, E. Valassopoulou, F. Verhelst, E. Peeters, S. Pype, C. De Vos, D. Strens, I. Vandersmissen

ABSTRACT

ObjectiveTreatment-resistant depression (TRD), a subgroup of major depressive disorder (MDD) that does not adequately respond to treatment, has a substantial impact on the quality of life of patients and is associated with higher medical and mental health care costs. This study aimed to report real-world treatment patterns, outcomes, resource utilization, and costs in the management of TRD by psychiatrists in Belgium.MethodsWe conducted a retrospective, non-interventional cohort study of patients ≥ 18 years, with diagnosed MDD who are treatment-resistant, defined as not responding to two different antidepressant treatments in the current moderate to severe major depressive episode (MDE). Data obtained from medical records of patients included patient health state (MDE, response, remission, and recovery) and resource use (number of consultations and emergency room visits, non-drug and drug interventions, and hospitalizations).ResultsOne hundred and twenty-five patients were enrolled in nine sites, with an average observation period of 34 months. During the MDE, 89.7% of patients were treated with selective serotonin reuptake inhibitors, 63.2% with serotonin-norepinephrine reuptake inhibitors, and 60.8% with anti-psychotics. Twenty-four percent of patients did not respond to any treatment; 76% responded, of whom 61% experienced a relapse; 28% of patients reached recovery, of whom 31.4% experienced recurrence. The average yearly direct cost of a TRD patient is €9012, mainly driven by hospitalization in the MDE. The observed absenteeism relates to a high indirect cost, representing 70% of the total MDE cost.ConclusionTRD is associated with a high unmet need and economic burden for patients and society, with highest costs in the MDE health state driven by absenteeism. More... »

PAGES

1-10

Identifiers

URI

http://scigraph.springernature.com/pub.10.1007/s41669-021-00306-2

DOI

http://dx.doi.org/10.1007/s41669-021-00306-2

DIMENSIONS

https://app.dimensions.ai/details/publication/pub.1142601350

PUBMED

https://www.ncbi.nlm.nih.gov/pubmed/34782984


Indexing Status Check whether this publication has been indexed by Scopus and Web Of Science using the SN Indexing Status Tool
Incoming Citations Browse incoming citations for this publication using opencitations.net

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Medical and Health Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1103", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Clinical Sciences", 
        "type": "DefinedTerm"
      }, 
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1117", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "name": "Public Health and Health Services", 
        "type": "DefinedTerm"
      }
    ], 
    "author": [
      {
        "affiliation": {
          "alternateName": "Clinique Saint Pierre, Ottignies, Belgium", 
          "id": "http://www.grid.ac/institutes/grid.477044.4", 
          "name": [
            "Clinique Saint Pierre, Ottignies, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Gillain", 
        "givenName": "B.", 
        "id": "sg:person.01026050155.40", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026050155.40"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "AZ Alma, Eeklo, Belgium", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Psychiatric Center Guislain, Ghent, Belgium", 
            "Private Practice, Maldegem, Belgium", 
            "AZ Alma, Eeklo, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Degraeve", 
        "givenName": "G.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Mentona Centre for Psychiatry and Psychotherapy, Bilzen, Belgium", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Mentona Centre for Psychiatry and Psychotherapy, Bilzen, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Dreesen", 
        "givenName": "T.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Psychiatric Center Ariadne, Lede, Belgium", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Psychiatric Center Ariadne, Lede, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "De Bruecker", 
        "givenName": "G.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Medical Center Anima, Alken, Belgium", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Medical Center Anima, Alken, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Buntinx", 
        "givenName": "E.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Psychiatric Center Menen, Menen, Belgium", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Psychiatric Center Menen, Menen, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Beke", 
        "givenName": "D.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier R\u00e9gional de Huy, Huy, Belgium", 
          "id": "http://www.grid.ac/institutes/grid.419763.e", 
          "name": [
            "Centre Hospitalier R\u00e9gional de Huy, Huy, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Kestens", 
        "givenName": "C.", 
        "id": "sg:person.010712311411.97", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010712311411.97"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Centre Hospitalier R\u00e9gional de la Citadelle, Li\u00e8ge, Belgium", 
          "id": "http://www.grid.ac/institutes/grid.413914.a", 
          "name": [
            "Centre Hospitalier R\u00e9gional de la Citadelle, Li\u00e8ge, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Valassopoulou", 
        "givenName": "E.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Grand H\u00f4pital de Charleroi, Charleroi, Belgium", 
          "id": "http://www.grid.ac/institutes/grid.490655.b", 
          "name": [
            "Grand H\u00f4pital de Charleroi, Charleroi, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Verhelst", 
        "givenName": "F.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department Medical Affairs, Janssen-Cilag NV, Beerse, Belgium", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department Medical Affairs, Janssen-Cilag NV, Beerse, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Peeters", 
        "givenName": "E.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department Medical Affairs, Janssen-Cilag NV, Beerse, Belgium", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department Medical Affairs, Janssen-Cilag NV, Beerse, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Pype", 
        "givenName": "S.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department Market Access, Janssen-Cilag NV, Antwerpseweg 15-17, 2340, Beerse, Belgium", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department Market Access, Janssen-Cilag NV, Antwerpseweg 15-17, 2340, Beerse, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "De Vos", 
        "givenName": "C.", 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Realidad bvba, Grimbergen, Belgium", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Realidad bvba, Grimbergen, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Strens", 
        "givenName": "D.", 
        "id": "sg:person.0703421760.54", 
        "sameAs": [
          "https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0703421760.54"
        ], 
        "type": "Person"
      }, 
      {
        "affiliation": {
          "alternateName": "Department Market Access, Janssen-Cilag NV, Antwerpseweg 15-17, 2340, Beerse, Belgium", 
          "id": "http://www.grid.ac/institutes/None", 
          "name": [
            "Department Market Access, Janssen-Cilag NV, Antwerpseweg 15-17, 2340, Beerse, Belgium"
          ], 
          "type": "Organization"
        }, 
        "familyName": "Vandersmissen", 
        "givenName": "I.", 
        "type": "Person"
      }
    ], 
    "datePublished": "2021-11-15", 
    "datePublishedReg": "2021-11-15", 
    "description": "ObjectiveTreatment-resistant depression (TRD), a subgroup of major depressive disorder (MDD) that does not adequately respond to treatment, has a substantial impact on the quality of life of patients and is associated with higher medical and mental health care costs. This study aimed to report real-world treatment patterns, outcomes, resource utilization, and costs in the management of TRD by psychiatrists in Belgium.MethodsWe conducted a retrospective, non-interventional cohort study of patients \u2265\u00a018 years, with diagnosed MDD who are treatment-resistant, defined as not responding to two different antidepressant treatments in the current moderate to severe major depressive episode (MDE). Data obtained from medical records of patients included patient health state (MDE, response, remission, and recovery) and resource use (number of consultations and emergency room visits, non-drug and drug interventions, and hospitalizations).ResultsOne hundred and twenty-five patients were enrolled in nine sites, with an average observation period of 34 months. During the MDE, 89.7% of patients were treated with selective serotonin reuptake inhibitors, 63.2% with serotonin-norepinephrine reuptake inhibitors, and 60.8% with anti-psychotics. Twenty-four percent of patients did not respond to any treatment; 76% responded, of whom 61% experienced a relapse; 28% of patients reached recovery, of whom 31.4% experienced recurrence. The average yearly direct cost of a TRD patient is \u20ac9012, mainly driven by hospitalization in the MDE. The observed absenteeism relates to a high indirect cost, representing 70% of the total MDE cost.ConclusionTRD is associated with a high unmet need and economic burden for patients and society, with highest costs in the MDE health state driven by absenteeism.", 
    "genre": "article", 
    "id": "sg:pub.10.1007/s41669-021-00306-2", 
    "inLanguage": "en", 
    "isAccessibleForFree": true, 
    "isPartOf": [
      {
        "id": "sg:journal.1284515", 
        "issn": [
          "2509-4262", 
          "2509-4254"
        ], 
        "name": "PharmacoEconomics - Open", 
        "publisher": "Springer Nature", 
        "type": "Periodical"
      }
    ], 
    "keywords": [
      "major depressive episode", 
      "major depressive disorder", 
      "real-world treatment patterns", 
      "cohort study", 
      "treatment patterns", 
      "reuptake inhibitors", 
      "depressive disorder", 
      "treatment-resistant major depressive disorder", 
      "severe major depressive episode", 
      "serotonin-norepinephrine reuptake inhibitors", 
      "non-interventional cohort study", 
      "selective serotonin reuptake inhibitors", 
      "different antidepressant treatments", 
      "percent of patients", 
      "retrospective cohort study", 
      "mental health care costs", 
      "serotonin reuptake inhibitors", 
      "average observation period", 
      "high unmet need", 
      "quality of life", 
      "health care costs", 
      "health states", 
      "higher indirect costs", 
      "patient's health state", 
      "antidepressant treatment", 
      "TRD patients", 
      "depressive episode", 
      "ResultsOne hundred", 
      "medical records", 
      "patients", 
      "economic burden", 
      "unmet need", 
      "care costs", 
      "observation period", 
      "indirect costs", 
      "direct costs", 
      "treatment", 
      "disorders", 
      "outcomes", 
      "inhibitors", 
      "resource utilization", 
      "absenteeism", 
      "hospitalization", 
      "relapse", 
      "recurrence", 
      "resource use", 
      "MethodsWe", 
      "study", 
      "months", 
      "depression", 
      "subgroups", 
      "psychiatrists", 
      "episodes", 
      "burden", 
      "substantial impact", 
      "percent", 
      "patterns", 
      "years", 
      "high cost", 
      "management", 
      "period", 
      "TRD", 
      "records", 
      "recovery", 
      "life", 
      "Belgium", 
      "utilization", 
      "use", 
      "need", 
      "data", 
      "quality", 
      "sites", 
      "impact", 
      "cost", 
      "state", 
      "society", 
      "hundreds", 
      "ObjectiveTreatment-resistant depression", 
      "management of TRD", 
      "average yearly direct cost", 
      "yearly direct cost", 
      "observed absenteeism", 
      "total MDE cost", 
      "MDE cost", 
      "ConclusionTRD", 
      "MDE health state"
    ], 
    "name": "Real-World Treatment Patterns, Outcomes, Resource Utilization and Costs in Treatment-Resistant Major Depressive Disorder: PATTERN, a Retrospective Cohort Study in Belgium", 
    "pagination": "1-10", 
    "productId": [
      {
        "name": "dimensions_id", 
        "type": "PropertyValue", 
        "value": [
          "pub.1142601350"
        ]
      }, 
      {
        "name": "doi", 
        "type": "PropertyValue", 
        "value": [
          "10.1007/s41669-021-00306-2"
        ]
      }, 
      {
        "name": "pubmed_id", 
        "type": "PropertyValue", 
        "value": [
          "34782984"
        ]
      }
    ], 
    "sameAs": [
      "https://doi.org/10.1007/s41669-021-00306-2", 
      "https://app.dimensions.ai/details/publication/pub.1142601350"
    ], 
    "sdDataset": "articles", 
    "sdDatePublished": "2022-01-01T19:02", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "s3://com-springernature-scigraph/baseset/20220101/entities/gbq_results/article/article_896.jsonl", 
    "type": "ScholarlyArticle", 
    "url": "https://doi.org/10.1007/s41669-021-00306-2"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1007/s41669-021-00306-2'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1007/s41669-021-00306-2'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1007/s41669-021-00306-2'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1007/s41669-021-00306-2'


 

This table displays all metadata directly associated to this object as RDF triples.

254 TRIPLES      21 PREDICATES      111 URIs      102 LITERALS      5 BLANK NODES

Subject Predicate Object
1 sg:pub.10.1007/s41669-021-00306-2 schema:about anzsrc-for:11
2 anzsrc-for:1103
3 anzsrc-for:1117
4 schema:author Nb7b4eb527f0b414da80eeada3bac879f
5 schema:datePublished 2021-11-15
6 schema:datePublishedReg 2021-11-15
7 schema:description ObjectiveTreatment-resistant depression (TRD), a subgroup of major depressive disorder (MDD) that does not adequately respond to treatment, has a substantial impact on the quality of life of patients and is associated with higher medical and mental health care costs. This study aimed to report real-world treatment patterns, outcomes, resource utilization, and costs in the management of TRD by psychiatrists in Belgium.MethodsWe conducted a retrospective, non-interventional cohort study of patients ≥ 18 years, with diagnosed MDD who are treatment-resistant, defined as not responding to two different antidepressant treatments in the current moderate to severe major depressive episode (MDE). Data obtained from medical records of patients included patient health state (MDE, response, remission, and recovery) and resource use (number of consultations and emergency room visits, non-drug and drug interventions, and hospitalizations).ResultsOne hundred and twenty-five patients were enrolled in nine sites, with an average observation period of 34 months. During the MDE, 89.7% of patients were treated with selective serotonin reuptake inhibitors, 63.2% with serotonin-norepinephrine reuptake inhibitors, and 60.8% with anti-psychotics. Twenty-four percent of patients did not respond to any treatment; 76% responded, of whom 61% experienced a relapse; 28% of patients reached recovery, of whom 31.4% experienced recurrence. The average yearly direct cost of a TRD patient is €9012, mainly driven by hospitalization in the MDE. The observed absenteeism relates to a high indirect cost, representing 70% of the total MDE cost.ConclusionTRD is associated with a high unmet need and economic burden for patients and society, with highest costs in the MDE health state driven by absenteeism.
8 schema:genre article
9 schema:inLanguage en
10 schema:isAccessibleForFree true
11 schema:isPartOf sg:journal.1284515
12 schema:keywords Belgium
13 ConclusionTRD
14 MDE cost
15 MDE health state
16 MethodsWe
17 ObjectiveTreatment-resistant depression
18 ResultsOne hundred
19 TRD
20 TRD patients
21 absenteeism
22 antidepressant treatment
23 average observation period
24 average yearly direct cost
25 burden
26 care costs
27 cohort study
28 cost
29 data
30 depression
31 depressive disorder
32 depressive episode
33 different antidepressant treatments
34 direct costs
35 disorders
36 economic burden
37 episodes
38 health care costs
39 health states
40 high cost
41 high unmet need
42 higher indirect costs
43 hospitalization
44 hundreds
45 impact
46 indirect costs
47 inhibitors
48 life
49 major depressive disorder
50 major depressive episode
51 management
52 management of TRD
53 medical records
54 mental health care costs
55 months
56 need
57 non-interventional cohort study
58 observation period
59 observed absenteeism
60 outcomes
61 patient's health state
62 patients
63 patterns
64 percent
65 percent of patients
66 period
67 psychiatrists
68 quality
69 quality of life
70 real-world treatment patterns
71 records
72 recovery
73 recurrence
74 relapse
75 resource use
76 resource utilization
77 retrospective cohort study
78 reuptake inhibitors
79 selective serotonin reuptake inhibitors
80 serotonin reuptake inhibitors
81 serotonin-norepinephrine reuptake inhibitors
82 severe major depressive episode
83 sites
84 society
85 state
86 study
87 subgroups
88 substantial impact
89 total MDE cost
90 treatment
91 treatment patterns
92 treatment-resistant major depressive disorder
93 unmet need
94 use
95 utilization
96 yearly direct cost
97 years
98 schema:name Real-World Treatment Patterns, Outcomes, Resource Utilization and Costs in Treatment-Resistant Major Depressive Disorder: PATTERN, a Retrospective Cohort Study in Belgium
99 schema:pagination 1-10
100 schema:productId N17f7541436c643d48d07ccbaba2573dc
101 N4d69423bd7f04b9a8da1008fd4766ec8
102 Nf43eb1787df54ace8a430fc103264310
103 schema:sameAs https://app.dimensions.ai/details/publication/pub.1142601350
104 https://doi.org/10.1007/s41669-021-00306-2
105 schema:sdDatePublished 2022-01-01T19:02
106 schema:sdLicense https://scigraph.springernature.com/explorer/license/
107 schema:sdPublisher Na64e72f14aa44baa88458130188ad89e
108 schema:url https://doi.org/10.1007/s41669-021-00306-2
109 sgo:license sg:explorer/license/
110 sgo:sdDataset articles
111 rdf:type schema:ScholarlyArticle
112 N01cdde49d91b47c98199d83977921957 rdf:first N6c8d71b2ed0d42c4b4ffa0e89b248426
113 rdf:rest rdf:nil
114 N0aa7d18a894f41f6896e16ff42c95011 rdf:first N9b936d00e01e4ee2b917a67ef4fd9766
115 rdf:rest N4aa452154e2147ab995bb51f3f1910b0
116 N17f7541436c643d48d07ccbaba2573dc schema:name pubmed_id
117 schema:value 34782984
118 rdf:type schema:PropertyValue
119 N4aa452154e2147ab995bb51f3f1910b0 rdf:first sg:person.010712311411.97
120 rdf:rest N596e3499078f4dfea40338b9d76de4c6
121 N4d69423bd7f04b9a8da1008fd4766ec8 schema:name doi
122 schema:value 10.1007/s41669-021-00306-2
123 rdf:type schema:PropertyValue
124 N4e4c9f27e07244e3ab343b7fa0c32d88 rdf:first N64091dfab0344fd0b899e23d9574c632
125 rdf:rest N6d93c88357814e97a54979c0bcc0106f
126 N58648b1234fe4782b403ca1d22dcb890 schema:affiliation grid-institutes:None
127 schema:familyName De Vos
128 schema:givenName C.
129 rdf:type schema:Person
130 N596e3499078f4dfea40338b9d76de4c6 rdf:first Nb7ad5d1189fb4528aa9114e405c39b97
131 rdf:rest Nd3fc2906c1d84405a477720c415984d8
132 N5bfc93b5bfd2478c92b8739eee39f84d schema:affiliation grid-institutes:None
133 schema:familyName Buntinx
134 schema:givenName E.
135 rdf:type schema:Person
136 N64091dfab0344fd0b899e23d9574c632 schema:affiliation grid-institutes:None
137 schema:familyName Degraeve
138 schema:givenName G.
139 rdf:type schema:Person
140 N65b1cba70ced42f8bf76bb4ac80607d1 rdf:first N5bfc93b5bfd2478c92b8739eee39f84d
141 rdf:rest N0aa7d18a894f41f6896e16ff42c95011
142 N6c8d71b2ed0d42c4b4ffa0e89b248426 schema:affiliation grid-institutes:None
143 schema:familyName Vandersmissen
144 schema:givenName I.
145 rdf:type schema:Person
146 N6cedae3d3d954b54a5f32746f8344cf7 schema:affiliation grid-institutes:None
147 schema:familyName Dreesen
148 schema:givenName T.
149 rdf:type schema:Person
150 N6d73401cd146423083114f87d7db0c15 rdf:first N82a4d2b97f4543a2921582ff5200f5f7
151 rdf:rest Nf675b5f7d0c94b71ad4da8ab2ddec6a6
152 N6d93c88357814e97a54979c0bcc0106f rdf:first N6cedae3d3d954b54a5f32746f8344cf7
153 rdf:rest N7303a8702fb74e17acd1855ea34ea031
154 N7303a8702fb74e17acd1855ea34ea031 rdf:first Nca0710e704444993be0fe9b005151f9a
155 rdf:rest N65b1cba70ced42f8bf76bb4ac80607d1
156 N79c7a39626cd4e3f8ff318fd9129a98a rdf:first sg:person.0703421760.54
157 rdf:rest N01cdde49d91b47c98199d83977921957
158 N82a4d2b97f4543a2921582ff5200f5f7 schema:affiliation grid-institutes:None
159 schema:familyName Pype
160 schema:givenName S.
161 rdf:type schema:Person
162 N915d2c5fdc1e47d695706f56df5866e3 rdf:first N9c3e37cb480b480c90300cefc97291e5
163 rdf:rest N6d73401cd146423083114f87d7db0c15
164 N9b936d00e01e4ee2b917a67ef4fd9766 schema:affiliation grid-institutes:None
165 schema:familyName Beke
166 schema:givenName D.
167 rdf:type schema:Person
168 N9c3e37cb480b480c90300cefc97291e5 schema:affiliation grid-institutes:None
169 schema:familyName Peeters
170 schema:givenName E.
171 rdf:type schema:Person
172 Na64e72f14aa44baa88458130188ad89e schema:name Springer Nature - SN SciGraph project
173 rdf:type schema:Organization
174 Nb7ad5d1189fb4528aa9114e405c39b97 schema:affiliation grid-institutes:grid.413914.a
175 schema:familyName Valassopoulou
176 schema:givenName E.
177 rdf:type schema:Person
178 Nb7b4eb527f0b414da80eeada3bac879f rdf:first sg:person.01026050155.40
179 rdf:rest N4e4c9f27e07244e3ab343b7fa0c32d88
180 Nca0710e704444993be0fe9b005151f9a schema:affiliation grid-institutes:None
181 schema:familyName De Bruecker
182 schema:givenName G.
183 rdf:type schema:Person
184 Nd3fc2906c1d84405a477720c415984d8 rdf:first Ne73dd10f2bd3471eb5a8239548a9f6e4
185 rdf:rest N915d2c5fdc1e47d695706f56df5866e3
186 Ne73dd10f2bd3471eb5a8239548a9f6e4 schema:affiliation grid-institutes:grid.490655.b
187 schema:familyName Verhelst
188 schema:givenName F.
189 rdf:type schema:Person
190 Nf43eb1787df54ace8a430fc103264310 schema:name dimensions_id
191 schema:value pub.1142601350
192 rdf:type schema:PropertyValue
193 Nf675b5f7d0c94b71ad4da8ab2ddec6a6 rdf:first N58648b1234fe4782b403ca1d22dcb890
194 rdf:rest N79c7a39626cd4e3f8ff318fd9129a98a
195 anzsrc-for:11 schema:inDefinedTermSet anzsrc-for:
196 schema:name Medical and Health Sciences
197 rdf:type schema:DefinedTerm
198 anzsrc-for:1103 schema:inDefinedTermSet anzsrc-for:
199 schema:name Clinical Sciences
200 rdf:type schema:DefinedTerm
201 anzsrc-for:1117 schema:inDefinedTermSet anzsrc-for:
202 schema:name Public Health and Health Services
203 rdf:type schema:DefinedTerm
204 sg:journal.1284515 schema:issn 2509-4254
205 2509-4262
206 schema:name PharmacoEconomics - Open
207 schema:publisher Springer Nature
208 rdf:type schema:Periodical
209 sg:person.01026050155.40 schema:affiliation grid-institutes:grid.477044.4
210 schema:familyName Gillain
211 schema:givenName B.
212 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01026050155.40
213 rdf:type schema:Person
214 sg:person.010712311411.97 schema:affiliation grid-institutes:grid.419763.e
215 schema:familyName Kestens
216 schema:givenName C.
217 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.010712311411.97
218 rdf:type schema:Person
219 sg:person.0703421760.54 schema:affiliation grid-institutes:None
220 schema:familyName Strens
221 schema:givenName D.
222 schema:sameAs https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0703421760.54
223 rdf:type schema:Person
224 grid-institutes:None schema:alternateName AZ Alma, Eeklo, Belgium
225 Department Market Access, Janssen-Cilag NV, Antwerpseweg 15-17, 2340, Beerse, Belgium
226 Department Medical Affairs, Janssen-Cilag NV, Beerse, Belgium
227 Medical Center Anima, Alken, Belgium
228 Mentona Centre for Psychiatry and Psychotherapy, Bilzen, Belgium
229 Psychiatric Center Ariadne, Lede, Belgium
230 Psychiatric Center Menen, Menen, Belgium
231 Realidad bvba, Grimbergen, Belgium
232 schema:name AZ Alma, Eeklo, Belgium
233 Department Market Access, Janssen-Cilag NV, Antwerpseweg 15-17, 2340, Beerse, Belgium
234 Department Medical Affairs, Janssen-Cilag NV, Beerse, Belgium
235 Medical Center Anima, Alken, Belgium
236 Mentona Centre for Psychiatry and Psychotherapy, Bilzen, Belgium
237 Private Practice, Maldegem, Belgium
238 Psychiatric Center Ariadne, Lede, Belgium
239 Psychiatric Center Guislain, Ghent, Belgium
240 Psychiatric Center Menen, Menen, Belgium
241 Realidad bvba, Grimbergen, Belgium
242 rdf:type schema:Organization
243 grid-institutes:grid.413914.a schema:alternateName Centre Hospitalier Régional de la Citadelle, Liège, Belgium
244 schema:name Centre Hospitalier Régional de la Citadelle, Liège, Belgium
245 rdf:type schema:Organization
246 grid-institutes:grid.419763.e schema:alternateName Centre Hospitalier Régional de Huy, Huy, Belgium
247 schema:name Centre Hospitalier Régional de Huy, Huy, Belgium
248 rdf:type schema:Organization
249 grid-institutes:grid.477044.4 schema:alternateName Clinique Saint Pierre, Ottignies, Belgium
250 schema:name Clinique Saint Pierre, Ottignies, Belgium
251 rdf:type schema:Organization
252 grid-institutes:grid.490655.b schema:alternateName Grand Hôpital de Charleroi, Charleroi, Belgium
253 schema:name Grand Hôpital de Charleroi, Charleroi, Belgium
254 rdf:type schema:Organization
 




Preview window. Press ESC to close (or click here)


...